Offering Cervical Cancer Screening to Older Women
Launched by UNIVERSITY OF AARHUS · Oct 1, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether it’s a good idea to offer cervical cancer screening to women aged 65 to 69 in Denmark. The researchers want to see if a method called HPV self-sampling, where women collect their own samples for testing, is a suitable option for this age group. Currently, the screening program does not include these women, and the study aims to understand the impact of including them.
To participate in this trial, women need to be between 65 and 69 years old, live in Denmark, and should not have had a cervical screening or cytology test in the last five years. Unfortunately, women who have had a hysterectomy or have moved in or out of Denmark in the past year cannot take part. If you join the study, you will have the chance to learn more about cervical cancer screening and how self-sampling might work for you. This trial is currently recruiting participants who meet the eligibility criteria.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 65 to 69 years;
- • Resident in Denmark
- • No record of a cervical cytology or screening invitation in the past 5 years
- • Not registered as ineligible for screening
- Exclusion Criteria:
- • Death
- • Migration to or from Denmark
- • Moving to or from the CDR
- • Residing in the CDR, but having GP in another region
- • A record of hysterectomy
About University Of Aarhus
The University of Aarhus, a prestigious research institution located in Denmark, is dedicated to advancing medical science through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that encourages cutting-edge research and the development of novel therapeutic interventions. Committed to ethical standards and patient safety, the University of Aarhus aims to contribute to the global body of medical knowledge while enhancing healthcare outcomes through rigorous scientific inquiry and evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Randers, Randers Nø, Denmark
Randers, , Denmark
Patients applied
Trial Officials
Mette T Tranberg, post doc phd
Principal Investigator
Randers Regional Hospital, Central Denmark Region
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials